NCT05011305 Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis Status COMPLETED Phase PHASE2
NCT04998500 Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis Status UNKNOWN Phase NA
NCT04948840 Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis Status UNKNOWN Phase NA
NCT04934202 Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France Status UNKNOWN Phase N/A
NCT04931147 A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04925362 THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis) Status NOT_YET_RECRUITING Phase NA
NCT04831034 68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease Status UNKNOWN Phase EARLY_PHASE1
NCT04795570 Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk Factors Status UNKNOWN Phase N/A
NCT04669158 Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis Status COMPLETED Phase PHASE1/PHASE2
NCT04468100 Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT04423458 Evaluation of Advanced US Tools in Assessing Allograft Complications Status COMPLETED Phase N/A
NCT04001998 Healthy Volunteer Study Comparing Tablet and Capsule Formulations Status WITHDRAWN Phase PHASE1
NCT03979417 Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets Status COMPLETED Phase N/A
NCT03907540 Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 Status COMPLETED Phase PHASE1